BACKGROUND: Data on health-related quality of life (HRQoL) changes among Americans aged ≥65 following colorectal cancer (CRC) diagnosis and treatment are limited. This study compared HRQoL changes among CRC patients across stages from before to after diagnosis with matched noncancer controls. METHODS: This population-based study used the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey (MHOS) data set (1998-2007). Medicare Advantage beneficiaries diagnosed with CRC between their baseline and follow-up MHOS (n = 349) were matched to noncancer controls (n = 1745) using propensity scores. Mixed-effects analysis of covariance models estimated changes in HRQoL (measured by the Medical Outcomes Study Short Form-36/Veterans RAND 12-item Survey) and the ability to perform 6 activities of daily living (ADLs) between baseline and follow-up. Logistic regression models estimated odds ratios for ADL impairments and major depressive disorder (MDD) risk. RESULTS: Mean time between CRC diagnosis and follow-up MHOS was 12.3 ± 9.8 months. Compared with controls, CRC patients had significantly lower scores in all physical and mental health domains at follow-up. The greatest decrements were observed in physical health and were largely driven by declines in the 6 months postdiagnosis and in stage III and IV patients. At follow-up, CRC patients had greater overall ADL impairment and difficulty with dressing, eating, and getting in/out of chairs. CRC patients, particularly stage IV patients, had greater odds of being at risk for MDD relative to controls. CONCLUSIONS: This study further underscores the adverse effects of CRC on physical health and the need to support older Americans' basic self-care needs, with attention to later-stage patients' increased debility.
BACKGROUND: Data on health-related quality of life (HRQoL) changes among Americans aged ≥65 following colorectal cancer (CRC) diagnosis and treatment are limited. This study compared HRQoL changes among CRC patients across stages from before to after diagnosis with matched noncancer controls. METHODS: This population-based study used the Surveillance, Epidemiology, and End Results Medicare Health Outcomes Survey (MHOS) data set (1998-2007). Medicare Advantage beneficiaries diagnosed with CRC between their baseline and follow-up MHOS (n = 349) were matched to noncancer controls (n = 1745) using propensity scores. Mixed-effects analysis of covariance models estimated changes in HRQoL (measured by the Medical Outcomes Study Short Form-36/Veterans RAND 12-item Survey) and the ability to perform 6 activities of daily living (ADLs) between baseline and follow-up. Logistic regression models estimated odds ratios for ADL impairments and major depressive disorder (MDD) risk. RESULTS: Mean time between CRC diagnosis and follow-up MHOS was 12.3 ± 9.8 months. Compared with controls, CRC patients had significantly lower scores in all physical and mental health domains at follow-up. The greatest decrements were observed in physical health and were largely driven by declines in the 6 months postdiagnosis and in stage III and IV patients. At follow-up, CRC patients had greater overall ADL impairment and difficulty with dressing, eating, and getting in/out of chairs. CRC patients, particularly stage IV patients, had greater odds of being at risk for MDD relative to controls. CONCLUSIONS: This study further underscores the adverse effects of CRC on physical health and the need to support older Americans' basic self-care needs, with attention to later-stage patients' increased debility.
Authors: Catherine E Mosher; Joseph G Winger; Barbara A Given; Paul R Helft; Bert H O'Neil Journal: Psychooncology Date: 2015-08-27 Impact factor: 3.894
Authors: Jordan M Harrison; Matthew A Davis; Debra L Barton; Nancy K Janz; Susan J Pressler; Christopher R Friese Journal: Support Care Cancer Date: 2017-03-08 Impact factor: 3.603
Authors: Alfredo Selim; William Rogers; Shirley Qian; James A Rothendler; Erin E Kent; Lewis E Kazis Journal: Qual Life Res Date: 2018-04-19 Impact factor: 4.147
Authors: Andrew M Blakely; Dayana Chanson; F Lennie Wong; Oliver S Eng; Stephen M Sentovich; Kurt A Melstrom; Lily L Lai; Yuman Fong; Virginia Sun Journal: Support Care Cancer Date: 2019-11-15 Impact factor: 3.603
Authors: Bruno A Cisterna; Nazila Kamaly; Won Il Choi; Ali Tavakkoli; Omid C Farokhzad; Cristian Vilos Journal: Nanomedicine (Lond) Date: 2016-08-16 Impact factor: 5.307
Authors: Jennifer L Moss; Casey N Pinto; Scherezade K Mama; Maria Rincon; Erin E Kent; Mandi Yu; Kathleen A Cronin Journal: Qual Life Res Date: 2020-11-02 Impact factor: 4.147
Authors: N P Suppli; J D Bukh; T E Moffitt; A Caspi; C Johansen; V Albieri; A Tjønneland; L V Kessing; S O Dalton Journal: Transl Psychiatry Date: 2015-09-01 Impact factor: 6.222